To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis
Clinical trial NCT03331523 · COMPLETED
Trial details
- NCT number
- NCT03331523
- Sponsor
- Glenmark Pharmaceuticals Ltd. India
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-20
- Primary completion
- 2018-10-25
- Enrollment
- 643
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.